FindTrial
Sign In

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00241995
Enrollment
Unknown
Registered
2005-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2006-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diazepam, Lamotrigine, Memnatine, Placebo, Topiramate

Brief summary

The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Interventions

DRUGAnticonvulsants

Sponsors

St. Petersburg State Pavlov Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Alcohol dependence Alcohol withdrawal syndrome

Exclusion criteria

Drug dependence Major psychiatric diagnoses Severe somatic illness

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026